Leptomeningeal melanoma in childhood

Cancer

Volumn 86, Issue 5, 1999, Pages 878-886

  Makin, Guy W J ^a,e   Eden, Osborn B ^a   Lashford, Linda S ^a   Moppett, John ^b   Gerrard, Mary P ^b   Davies, Helena A ^c   Powell, Colin V E ^c   Campbell, Alastair N ^d   Child, H Frances ^d  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d ROYAL PRESTON HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Brain; Chemotherapy; Melanoma; Pediatric oncology

Indexed keywords

ANTIINFECTIVE AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DEXAMETHASONE; ETOPOSIDE; STEROID; VINCRISTINE;

ARTICLE; BRAIN METASTASIS; CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; MALE; MELANOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIODIAGNOSIS; SKIN MANIFESTATION; TREATMENT OUTCOME;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; FATAL OUTCOME; FEMALE; HUMANS; MALE; MELANOMA; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 0033198207     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990901)86:5<878::AID-CNCR26>3.0.CO;2-Y     Document Type: Article

References (58)

1. Virchow R. Pigment und diffuse melanose der arachnoides. Virchows Arch Pathol Anat 1859;16:180.
2. Aichner F, Schuler G. Primary leptomeningeal melanoma. Cancer 1982;50:1751-6.
3. Rokitansky J. Ein ausgezeichneter fall von pigment-mall mit ausgebreiteter pigmentirung der imenen hirn-und rückenmarkshäute. Allg Wien Med Z 1861;6:113-6.
4. Van Bogaert L. La melanosé neurocutaneé diffuse hérédofamiliale. Bull Acad R Med Belg 1948;13:397-428.
5. Kadonaga JN, Frieden IJ. Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol 1991;24:747-55.
6. Mehregan AH, Mehregan DA. Malignant melanoma in childhood. Cancer 1993;71:4096-103.
7. Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A. Cutaneous melanoma and atypical Spitz tumours in childhood. Cancer 1995;76:1833-45.
8. Ceballos PI, Ruiz-Maldonado R, Mihm MC. Melanoma in children. N Engl J Med 1995;332:656-62.
9. Pratt CB, Palmer MK, Thatcher N, Crowther D. Malignant melanoma in children and adolescents. Cancer 1981;47: 392-7.
10. Rodriguez-Galindo C, Pappo AS, Kaste SC, Rao BN, Cain A, Jenkins JJ, et al. Brain metastases in children with melanoma. Cancer 1997;79:2440-5.
11. Fox H, Emery JL, Goodbody RA, Yates PO. Neurocutaneous melanosis. Arch Dis Child 1964;39:508-16.
12. Fox H. Neurocutaneous melanosis. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Amsterdam: Elsevier, 1972:414-28.
13. Helseth A, Helseth E, Unsgard G. Primary meningeal melanoma. Acta Oncologica 1989;28:103-4.
14. Kaplan AM, Itabashi HH, Hanelin LG, Lu AT. Neurocutaneous melanosis with malignant leptomeningeal melanoma. Arch Neurol 1975;32:669-71.
15. Faillace WJ, Okawara SH, McDonald JV. Neurocutaneous melanosis with extensive intracerebral and spinal cord involvement. J Neurosurg 1984;61:782-5.
16. Thomas CS, Toone BK, Rose PE. Neurocutaneous melanosis and psychosis. Am J Psychiatr 1988;145:649-50.
17. Salisbury JR, Rose PE. Primary central nervous system malignant melanoma in the bathing trunk naevus syndrome. Postgrad Med J 1989;65:387-9.
18. Vadoud-Seyedi R, Heenen M. Neurocutaneous melanosis. Dermatology 1994;188:62-5.
19. Nicolaides P, Newton RW, Kelsey A. Primary malignant melanoma of meninges: atypical presentation of subacute meningitis. Pediatr Neurol 1995;12:172-4.
20. Leaney BJ, Rowe PW, Klug GL. Neurocutaneous melanosis with hydrocephalus and syringomyelia. J Neurosurg 1985;62: 148-52.
21. Hoffman HJ, Freeman A. Primary leptomeningeal melanoma in association with giant hairy nevi. J Neurosurg 1967; 26:62-71.
22. Allcutt D, Michowiz S, Weitzman S, Becker L, Blaser S, Hoffman HJ, et al. Primary meningeal melanoma: an unusually aggressive tumour in childhood. Neurosurgery 1993;32: 721-9.
23. Meister L, Rackoff W, Arendash-Durand B. Lepto-meningeal melanosis. Med Pediatr Oncol 1991;19:42-7.
24. Eaves FF, Burstein FD, Hudgins R, Cohen SR, Papciak M, et al. Primary temporal melanoma without diffuse leptomeningeal involvement: a variant of neurocutaneous melanosis. Plast Reconstr Surg 1995;95:133-5.
25. Humes RA, Roskamp J, Eisebrey AB. Melanosis and hydrocephalus. J Neurosurg 1984;61:365-8.
26. Slaughter JC, Hardman JM, Kempe LG, Earle KM. Neurocutaneous melanosis and leptomeningeal melanomatosis in children. Arch Pathol 1969;88:298-304.
27. Lamas E, Diez Lobato R, Sotelo T, Ricoy JR, Castro S. Neurocutaneous melanosis. Acta Neurochir 1977;36:93-105.
28. Williams HI. Primary malignant meningeal melanoma associated with benign hairy naevi. J Pathol 1969;99:171-2.
29. Poe LB, Roitberg D, Galyon DD. Neurocutaneous melanosis presenting as an intradural mass of the cervical canal: magnetic resonance features and the presence of melanin as a clue to diagnosis: case report. Neurosurgery 1994;35:741-3.
30. DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Wasti Q, et al. Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol 1996;35:529-38.
31. Marghoob AA, Schoenbach SP, Kopf AW, Orlow SJ, Nossa R, Bart RS. Large congenital melanocytic nevi and the risk for development of malignant melanoma. Arch Dermatol 1996; 132:170-5.
32. Zuniga S, Las Heras J, Benveniste S. Rhabdomyosarcoma arising in a congenital giant nevus associated with neurocutaneous melanosis in a neonate. J Pediatr Surg 1987;22: 1036-8.
33. Narayanan HS, Gandhi DH, Girimaji SR. Neurocutaneous melanosis associated with Dandy-Walker syndrome. Clin Neurol Neurosurg 1987;89:197-200.
34. Kadonaga JN, Barkovich AJ, Edwards MSB, Frieden IJ. Neurocutaneous melanosis in association with the Dandy-Walker complex. Pediatr Dermatol 1992;9:37-43.
35. Ko SF, Wang HS, Lui TN, Ng SH, Ho YS, Tsai CC. Neurocutaneous melanosis associated with inferior vermian hypoplasia: MR findings. J Comput Assist Tomogr 1993;17:692-5.
36. Sebag G, Dubois J, Pfister P, Brunelle F, St-Rose C. Neurocutaneous melanosis and temporal lobe tumour in a child: MR study. Am J Neuroradiol 1991;12:699-700.
37. Barkovich AJ, Frieden IJ, Williams ML. MR of neurocutaneous melanosis. Am J Neuroradiol 1994;15:859-67.
38. Rhodes RE, Friedman HS, Hatten HP, Hockenberger B, Oakes WJ, Tomita T. Contrast enhanced MR imaging of neurocutaneous melanosis. Am J Neuroradiol 1991;12: 380-2.
39. Frieden IJ, Williams ML, Barkovich AJ. Giant congenital melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children. J Am Acad Dermatol 1994;31:423-9.
40. Ellis DS, Spencer WH, Stephenson CM. Congenital neurocutaneous melanosis with metastatic orbital malignant melanoma. Ophthalmology 1986;93:1639-42.
41. Reyes-Mugica M, Chou P, Byrd S, Ray V, Castelli M, Gattuso P, et al. Nevomelanocytic proliferations in the central nervous system of children. Cancer 1993;72:2277-85.
42. Hayes FA, Green AA. Malignant melanoma in childhood: clinical course and response to therapy. J Clin Oncol 1984; 2:1229-34.
43. Boddie AW, Cangir A. Adjuvant and neoadjuvant chemotherapy with dacarbazine in high risk childhood melanoma. Cancer 1987;60:1720-23.
44. Beresford HR. Melanoma of the nervous system, treatment with corticosteroids and radiation. Neurology 1969;19:59-65.
45. Katz HR. The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system. Int J Radiat Oncol Biol Phys 1981;7:897-906.
46. Katz HR. The results of different fractionation schemes in the palliative irradiation of metastatic melanoma. Int J Radiat Oncol Biol Phys 1981;7:907-11.
47. Gupta G, Robertson AG, MacKie RM. Cerebral metastases of cutaneous melanoma. Br J Cancer 1997;76:256-9.
48. Hill GJ, Ruess R, Berris R, Philpott GW, Parkin P. Chemotherapy of malignant melanoma with dimethyl triazeno imidazole carboxamide (DTIC) and nitrosourea derivatives (BCNU, CCNU). Ann Surg 1974;180:167-74.
49. Luce JK. Chemotherapy of melanoma. Semin Oncol 1975;2: 179-85.
50. Anderson CM, Buzaid AC, Legha SS. Systemic treatments for advanced cutaneous melanoma. Oncology 1995;9:1149-58.
51. Falkson CI. Treatment of metastatic malignant melanoma. Anticancer Drugs 1995;6:709-16.
52. Bleehen NM, Newlands ES, Lee SM, Thatcher N, Selby P, Calvert AH, et al. Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol 1995; 13:910-3.
53. Morton DL, Eilber FR, Holmes EC, Hunt JS, Ketcham AS, Silverstein MJ, et al. BCG immunotherapy of malignant melanoma: summary of a seven year experience. Ann Surg 1974;180:635-43.
54. Rosenberg SA, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin-2. JAMA 1994;271:907-13.
55. Fathallah-Shaykh HM, Zimmerman C, Morgan H, Rushing E, Schold SC, Unwin DH. Response of primary leptomeningeal melanoma to intrathecal recombinant interleukin-2. Cancer 1996;77:1544-50.
56. Heimans JJ, Wagstaff J, Schreuder WO, Wolbers JG, Baars JW, Polman CH, et al. Treatment of leptomeningeal carcinomatosis with continuous intraventricular infusion of recombinant interleukin-2. Surg Neurol 1991;35:244-7.
57. Proebstle TM, Scheibenbogen C, Sterry W, Keilholz U. A phase II study of dacarbazine, cisplatin, interferon α and high dose interleukin-2 in "poor-risk" metastatic melanoma. Eur J Cancer 1996;32:1530-3.
58. Punt CJA, van Herpen CML, Jansen RLH, Vreugdenhil G, Muller EW, de Mulder PHM. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon α for metastatic melanoma: a multicentre phase II study. Br J Cancer 1997;76:266-9.